Answer
Pazopanib is indicated for first-line treatment of adults with advanced renal cell carcinoma and for adults who have received prior cytokine therapy for advanced disease.
Sources for this answer
- Pazopanib 200 mg film-coated tabletsDr. Reddy's Laboratories (UK) Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated
Sources checked